BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 18410173)

  • 1. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder.
    Kantak KM; Singh T; Kerstetter KA; Dembro KA; Mutebi MM; Harvey RC; Deschepper CF; Dwoskin LP
    Behav Neurosci; 2008 Apr; 122(2):340-57. PubMed ID: 18410173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneously hypertensive and Wistar Kyoto rats differ in delayed matching-to-place performance and response to dietary long-chain polyunsaturated fatty acids.
    Clements KM; Girard TA; Xing HC; Wainwright PE
    Dev Psychobiol; 2003 Jul; 43(1):57-69. PubMed ID: 12794779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
    van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
    Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
    Ueno K; Togashi H; Yoshioka M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats differ in performance on a win-shift task in the water radial arm maze.
    Clements KM; Wainwright PE
    Behav Brain Res; 2006 Feb; 167(2):295-304. PubMed ID: 16293322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response acquisition with delayed reinforcement in a rodent model of attention-deficit/hyperactivity disorder (ADHD).
    Hand DJ; Fox AT; Reilly MP
    Behav Brain Res; 2006 Dec; 175(2):337-42. PubMed ID: 17034874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
    Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
    Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneously hypertensive rat (SHR) as an animal model for ADHD: a short overview.
    Meneses A; Perez-Garcia G; Ponce-Lopez T; Tellez R; Gallegos-Cari A; Castillo C
    Rev Neurosci; 2011; 22(3):365-71. PubMed ID: 21591908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD).
    Pires VA; Pamplona FA; Pandolfo P; Prediger RD; Takahashi RN
    Behav Brain Res; 2010 Dec; 215(1):39-44. PubMed ID: 20600342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneously hypertensive, Wistar Kyoto and Sprague-Dawley rats differ in performance on a win-stay task and a conditioned cue preference task in the water radial arm maze.
    Clements KM; Wainwright PE
    Behav Brain Res; 2007 Nov; 183(2):169-77. PubMed ID: 17664015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline behavior, but not sensitivity to stimulant drugs, differs among spontaneously hypertensive, Wistar-Kyoto, and Sprague-Dawley rat strains.
    Ferguson SA; Paule MG; Cada A; Fogle CM; Gray EP; Berry KJ
    Neurotoxicol Teratol; 2007; 29(5):547-61. PubMed ID: 17689921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spontaneously hypertensive rat/Izm (SHR/Izm) shows attention deficit/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate.
    Kishikawa Y; Kawahara Y; Yamada M; Kaneko F; Kawahara H; Nishi A
    Behav Brain Res; 2014 Nov; 274():235-42. PubMed ID: 25151620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems with spontaneously hypertensive rats (SHR) as a model of attention-deficit/hyperactivity disorder (AD/HD).
    Alsop B
    J Neurosci Methods; 2007 May; 162(1-2):42-8. PubMed ID: 17241669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder.
    Jensen V; Rinholm JE; Johansen TJ; Medin T; Storm-Mathisen J; Sagvolden T; Hvalby O; Bergersen LH
    Neuroscience; 2009 Jan; 158(1):353-64. PubMed ID: 18571865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The working memory capabilities of the spontaneously hypertensive rat.
    Robertson BA; Clements KM; Wainwright PE
    Physiol Behav; 2008 Jun; 94(3):481-6. PubMed ID: 18452958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder.
    Cao AH; Yu L; Wang YW; Wang JM; Yang LJ; Lei GF
    Behav Brain Funct; 2012 Feb; 8(1):10. PubMed ID: 22369105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS; Kantak KM; Dwoskin LP
    J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
    Liu LL; Yang J; Lei GF; Wang GJ; Wang YW; Sun RP
    Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):527-32. PubMed ID: 18346050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
    Howells FM; Russell VA
    Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.